ShockWave Medical (SWAV) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

CoronaryPeripheral
038M75M112M150M188M225M262M300MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Revenue by Geography

UNITED STATESEuropeAll Other Countries
038M75M112M150M188M225M262M300MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
075M150M225M300M375M450M525M600MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
025M50M75M100M125M150M175M200MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

EBITDA

EBITDA
010M20M30M40M50M60M70M80MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

EPS

EPSEPS Diluted
001222344Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Revenue Variation (%)

Revenue Variation
02581012151820Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0918263544526170Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Revenue YoY Variation (%)

Revenue YoY Variation
01122344556687990Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
062125188250312375438500Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Price-to-Earning Ratio

P/E Ratio
0255075100125150175200Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
03875112150188225262300Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
025M50M75M100M125M150M175M200MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
0124568910Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
025M50M75M100M125M150M175M200MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024

Cash Flow to Debt Ratio

Cash At End Of Period
075M150M225M300M375M450M525M600MQ1 2023Q2 2023Q3 2023Q4 2023Q1 2024
🏦 Balance Sheet
📈 Key Metrics